Some of the SPOP residues for which there are NMR chemical shift perturbations (Fig. 1j) are frequently mutated in patients with prostate cancer (Tyr87, Phe125, Trp131, and Phe133) and endometrial cancer (Met117)27,29. This evidence concerns the gene SPOP and prostate carcinoma.